Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03344276 · ClinicalTrials.gov registry record · NA
Assessing Neurocognition After Cerebrovascular Intervention
A NA study of Carotid Artery Diseases and Neurocognitive Dysfunction, sponsored by University of California, San Diego.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT03344276 is a NA study of Carotid Artery Diseases and Neurocognitive Dysfunction that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 20 participants, below the 1,671-participant average among 6 other Carotid Artery Diseases trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03344276, a NA study of Carotid Artery Diseases and Neurocognitive Dysfunction, is actively recruiting participants, sponsored by University of California, San Diego.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Decreased blood flow to the brain can cause decreased cognitive function. Carotid disease can result in decreased blood flow to the brain. The investigators seek to assess this relationship prospectively through performing a battery of neurocognitive assessments, collection of serum markers of inflammation, and through neuroimaging at two points before intervention (2 months and 1 month before stenting) and at two points after intervention (1 month and 2 months after intervention). The goal is to provide prospective evidence to identify the extent to which carotid stenosis and hypoperfusion of the brain results in diminished neurocognitive performance, and see if serum biomarkers before and after stenting correlate with these findings.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Neurocognitive Assessments
- DIAGNOSTIC_TEST Measurements of inflammatory biomarkers
- PROCEDURE Carotid Artery Stenting
Study Locations (1)
California
- UCSD Medical Center - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-07-15 |
| Est. Completion | 2025-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03344276
The ClinicalTrials.gov registry entry for NCT03344276 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,671-participant average among 6 other Carotid Artery Diseases trials with a reported enrollment target (99% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Carotid Artery Diseases appearing as the primary indexed condition, and to 3 interventions - of which Neurocognitive Assessments is the first listed.
NCT03344276 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03344276 about?
NCT03344276 is a clinical study titled "Assessing Neurocognition After Cerebrovascular Intervention". Decreased blood flow to the brain can cause decreased cognitive function. Carotid disease can result in decreased blood flow to the brain. The investigators seek to assess this relationship prospectively through performing a battery of neurocognitive assessments, collection of serum markers of infla...
What is the current status of trial NCT03344276?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2021-07-15. Estimated completion is 2025-12.
What conditions does trial NCT03344276 study?
This clinical trial studies the following conditions: Carotid Artery Diseases, Neurocognitive Dysfunction.
What interventions are being tested in trial NCT03344276?
The interventions under investigation include: Neurocognitive Assessments (DIAGNOSTIC_TEST), Measurements of inflammatory biomarkers (DIAGNOSTIC_TEST), Carotid Artery Stenting (PROCEDURE).
Who is sponsoring clinical trial NCT03344276?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03344276 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Carotid Artery Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Single-arm, Pivotal Study to Evaluate Acute Device and Technical Success of the CGuard Prime Carotid Stent System When Used in Conjunction to the ENROUTE Transcarotid Neuroprotection System in Patients Undergoing Carotid Artery Stenting Via the Transcarotid Artery Revascularization Approach
RECRUITING · NA
-
Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP System
ACTIVE NOT RECRUITING · NA
-
Study of Carotid Occlusion and Neurocognition
COMPLETED · NA
-
Direct Access Carotid Artery Stenting Using the Neuroguard IEP System (PERFORMANCE III)
COMPLETED · NA
-
The CREST-2 Registry
RECRUITING
-
Intervascular Post-Market Clinical Follow-Up (PMCF) Registry
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.